OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ethnic Diversity and Warfarin Pharmacogenomics
Innocent G. Asiimwe, Munir Pirmohamed
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 28
Innocent G. Asiimwe, Munir Pirmohamed
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Pharmacogenomics: current status and future perspectives
Munir Pirmohamed
Nature Reviews Genetics (2023) Vol. 24, Iss. 6, pp. 350-362
Closed Access | Times Cited: 163
Munir Pirmohamed
Nature Reviews Genetics (2023) Vol. 24, Iss. 6, pp. 350-362
Closed Access | Times Cited: 163
Addressing Ancestry and Sex Bias in Pharmacogenomics
Manuel Corpas, Moneeza K. Siddiqui, Opeyemi Soremekun, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 53-64
Open Access | Times Cited: 17
Manuel Corpas, Moneeza K. Siddiqui, Opeyemi Soremekun, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 53-64
Open Access | Times Cited: 17
A Chinese patient with cardiogenic stroke and warfarin resistance: a case report
Xiaoyan Du, Peng Zhang, Linhai Hu, et al.
BMC Neurology (2025) Vol. 25, Iss. 1
Open Access
Xiaoyan Du, Peng Zhang, Linhai Hu, et al.
BMC Neurology (2025) Vol. 25, Iss. 1
Open Access
Implementation of pre‐emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?
Elena Peruzzi, Rossana Roncato, Elena De Mattia, et al.
British Journal of Clinical Pharmacology (2023)
Open Access | Times Cited: 8
Elena Peruzzi, Rossana Roncato, Elena De Mattia, et al.
British Journal of Clinical Pharmacology (2023)
Open Access | Times Cited: 8
Drug–Drug–Gene Interactions in Cardiovascular Medicine
Innocent G. Asiimwe, Munir Pirmohamed
Pharmacogenomics and Personalized Medicine (2022) Vol. Volume 15, pp. 879-911
Open Access | Times Cited: 13
Innocent G. Asiimwe, Munir Pirmohamed
Pharmacogenomics and Personalized Medicine (2022) Vol. Volume 15, pp. 879-911
Open Access | Times Cited: 13
A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patients
Innocent G. Asiimwe, Marc Blockman, Karen Cohen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Innocent G. Asiimwe, Marc Blockman, Karen Cohen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
A Review of the Evolving Landscape of Inclusive Research and Improved Clinical Trial Access
Shalini Mohan, Jamie Freedman
Clinical Pharmacology & Therapeutics (2022) Vol. 113, Iss. 3, pp. 518-527
Open Access | Times Cited: 8
Shalini Mohan, Jamie Freedman
Clinical Pharmacology & Therapeutics (2022) Vol. 113, Iss. 3, pp. 518-527
Open Access | Times Cited: 8
The future of personalized cardiovascular medicine demands 3D and 4D printing, stem cells, and artificial intelligence
Monique Bax, Jordan Thorpe, Valentin Romanov
Frontiers in Sensors (2023) Vol. 4
Open Access | Times Cited: 4
Monique Bax, Jordan Thorpe, Valentin Romanov
Frontiers in Sensors (2023) Vol. 4
Open Access | Times Cited: 4
Meta-analysis of genome-wide association studies of stable warfarin dose in patients of African ancestry
Innocent G. Asiimwe, Marc Blockman, Larisa H. Cavallari, et al.
Blood Advances (2024) Vol. 8, Iss. 20, pp. 5248-5261
Open Access | Times Cited: 1
Innocent G. Asiimwe, Marc Blockman, Larisa H. Cavallari, et al.
Blood Advances (2024) Vol. 8, Iss. 20, pp. 5248-5261
Open Access | Times Cited: 1
Advancing Precision Medicine in Paediatrics: Past, present and future
Abdelbaset A. Elzagallaai, Charlotte Barker, Tamorah Lewis, et al.
Cambridge Prisms Precision Medicine (2023) Vol. 1
Open Access | Times Cited: 3
Abdelbaset A. Elzagallaai, Charlotte Barker, Tamorah Lewis, et al.
Cambridge Prisms Precision Medicine (2023) Vol. 1
Open Access | Times Cited: 3
Should secondary pharmacogenomic variants be actively screened and reported when diagnostic genome-wide sequencing is performed in a child?
Jan M. Friedman, Yvonne Bombard, Bruce Carleton, et al.
Genetics in Medicine (2023) Vol. 26, Iss. 2, pp. 101033-101033
Open Access | Times Cited: 3
Jan M. Friedman, Yvonne Bombard, Bruce Carleton, et al.
Genetics in Medicine (2023) Vol. 26, Iss. 2, pp. 101033-101033
Open Access | Times Cited: 3
Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates
Zeina N. Al‐Mahayri, Lubna Q. Khasawneh, Mais N. Alqasrawi, et al.
Human Genomics (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Zeina N. Al‐Mahayri, Lubna Q. Khasawneh, Mais N. Alqasrawi, et al.
Human Genomics (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 5
New insights into the role of VKORC1 polymorphisms for optimal warfarin dose selection in Caribbean Hispanic patients through an external validation of a population PK/PD model
Karine Rodríguez-Fernández, Gledys Reynaldo Fernández, Stephanie Reyes-González, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 115977-115977
Open Access | Times Cited: 2
Karine Rodríguez-Fernández, Gledys Reynaldo Fernández, Stephanie Reyes-González, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 115977-115977
Open Access | Times Cited: 2
A Chinese patient with cardiogenic stroke and warfarin resistance: A case report
Xiaoyan Du, Peng Zhang, Linhai Hu, et al.
Research Square (Research Square) (2024)
Open Access
Xiaoyan Du, Peng Zhang, Linhai Hu, et al.
Research Square (Research Square) (2024)
Open Access
Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test
Benoît Delabays, Katerina Trajanoska, Joshua Walonoski, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 5, pp. 791-827
Open Access
Benoît Delabays, Katerina Trajanoska, Joshua Walonoski, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 5, pp. 791-827
Open Access
A Paradigm Shift on Emergence of Pharmacogenomics in the Era of Personalized Medicine
Neha Kukreti, Khushi Lamba, Pankaj Pant, et al.
Advances in medical technologies and clinical practice book series (2024), pp. 1-34
Closed Access
Neha Kukreti, Khushi Lamba, Pankaj Pant, et al.
Advances in medical technologies and clinical practice book series (2024), pp. 1-34
Closed Access
Application of Pharmacogenetics for the Use of Antiplatelet and Anticoagulant Drugs
Sony Tuteja
Current Cardiovascular Risk Reports (2023) Vol. 17, Iss. 2, pp. 27-38
Closed Access | Times Cited: 1
Sony Tuteja
Current Cardiovascular Risk Reports (2023) Vol. 17, Iss. 2, pp. 27-38
Closed Access | Times Cited: 1
The African Liver Tissue Biorepository Consortium: Capacitating Population-Appropriate Drug Metabolism, Pharmacokinetics, and Pharmacogenetics Research in Drug Discovery and Development
Collen Masimirembwa, Michèle Ramsay, Jean Botha, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 12, pp. 1551-1560
Open Access | Times Cited: 1
Collen Masimirembwa, Michèle Ramsay, Jean Botha, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 12, pp. 1551-1560
Open Access | Times Cited: 1
Chinese stroke patients with atrial fibrillation used Robert's age-adjusted warfarin loading protocol obtained good INR results within therapeutic range
Weiliang Luo, Xuanwen Luo, Suqin Chen, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Weiliang Luo, Xuanwen Luo, Suqin Chen, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Establishment of a prediction algorithm for the Honghe minority group based on warfarin maintenance dose
Mengjiao Qian, Huan Zhao, Yunli Lou, et al.
Pharmacogenomics (2022) Vol. 23, Iss. 11, pp. 619-626
Closed Access | Times Cited: 1
Mengjiao Qian, Huan Zhao, Yunli Lou, et al.
Pharmacogenomics (2022) Vol. 23, Iss. 11, pp. 619-626
Closed Access | Times Cited: 1
Author comment: Advancing Precision Medicine in Paediatrics; Past, Present and Future — R1/PR5
Michael Rieder
(2022)
Open Access
Michael Rieder
(2022)
Open Access
Recommendation: Advancing Precision Medicine in Paediatrics; Past, Present and Future — R1/PR7
Abdelbaset Elzagallaai, Charlotte Barker, Tamorah Lewis, et al.
(2022)
Open Access
Abdelbaset Elzagallaai, Charlotte Barker, Tamorah Lewis, et al.
(2022)
Open Access
Recommendation: Advancing Precision Medicine in Paediatrics; Past, Present and Future — R0/PR3
Abdelbaset Elzagallaai, Charlotte Barker, Tamorah Lewis, et al.
(2022)
Open Access
Abdelbaset Elzagallaai, Charlotte Barker, Tamorah Lewis, et al.
(2022)
Open Access
Decision: Advancing Precision Medicine in Paediatrics; Past, Present and Future — R0/PR4
Abdelbaset Elzagallaai, Charlotte Barker, Tamorah Lewis, et al.
(2022)
Open Access
Abdelbaset Elzagallaai, Charlotte Barker, Tamorah Lewis, et al.
(2022)
Open Access
Review: Advancing Precision Medicine in Paediatrics; Past, Present and Future — R0/PR2
Abdelbaset Elzagallaai, Charlotte Barker, Tamorah Lewis, et al.
(2022)
Open Access
Abdelbaset Elzagallaai, Charlotte Barker, Tamorah Lewis, et al.
(2022)
Open Access
